MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q2
hinzugefügt 13.08.2025
DURECT Corporation Current Ratio 2011-2026 | DRRX
Current Ratio Jährlich DURECT Corporation
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 1.95 | 5.45 | 2.87 | 1.13 | 5.15 | 5.67 | 3.94 | 5.25 | 2.5 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 5.67 | 1.13 | 3.77 |
Current Ratio anderer Aktien in der Arzneimittelhersteller
| Name | Current Ratio | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
AcelRx Pharmaceuticals
ACRX
|
2.34 | - | 7.5 % | $ 6.35 M |  USA |
 |
Agile Therapeutics
AGRX
|
0.386 | - | 10.11 % | $ 58.2 M | USA |
 |
Alimera Sciences
ALIM
|
1.43 | - | - | $ 142 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
0.944 | - | 0.86 % | $ 117 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
0.961 | - | - | $ 754 M | USA |
 |
Cronos Group
CRON
|
6.63 | $ 2.64 | -1.12 % | $ 1.36 B |  Canada |
 |
Eagle Pharmaceuticals
EGRX
|
2.35 | - | -39.89 % | $ 27.7 M | USA |
 |
Endo International plc
ENDP
|
1.77 | - | - | $ 28.9 M |  Irlanda |
 |
Harrow Health
HROW
|
1.15 | $ 40.9 | 0.91 % | $ 1.5 B | USA |
 |
Catalent
CTLT
|
1.59 | - | - | $ 11.5 B | USA |
 |
Athenex
ATNX
|
0.894 | - | -23.39 % | $ 1.76 M | USA |
 |
Cumberland Pharmaceuticals
CPIX
|
1.43 | $ 4.36 | 4.06 % | $ 61.3 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
1.82 | - | - | $ 2.06 B |  France |
 |
Jupiter Wellness
JUPW
|
6.86 | - | - | $ 33.6 M | USA |
 |
Calliditas Therapeutics AB (publ)
CALT
|
9.82 | - | -0.1 % | $ 2.03 B |  Schweden |
 |
HEXO Corp.
HEXO
|
1.85 | - | 2.45 % | $ 38.1 M | Canada |
 |
Pacira BioSciences
PCRX
|
2 | $ 24.44 | -4.12 % | $ 1.13 B | USA |
 |
Solid Biosciences
SLDB
|
4.43 | $ 7.13 | -1.79 % | $ 624 M | USA |
 |
Evoke Pharma
EVOK
|
0.733 | - | - | $ 36.6 M | USA |
 |
Bausch Health Companies
BHC
|
0.997 | $ 5.65 | -1.22 % | $ 2.06 B | Canada |
 |
Canopy Growth Corporation
CGC
|
2.13 | $ 1.13 | 1.8 % | $ 122 M | Canada |
 |
Sonoma Pharmaceuticals
SNOA
|
1.48 | $ 1.2 | 9.09 % | $ 1.49 M | USA |
 |
Aurora Cannabis
ACB
|
3.49 | $ 3.48 | 1.16 % | $ 86.3 M | Canada |
 |
Tilray
TLRY
|
4.41 | $ 6.16 | -1.28 % | $ 3.81 B | Canada |
 |
Lannett Company
LCI
|
0.659 | - | 1.15 % | $ 7.11 M | USA |
 |
OrganiGram Holdings
OGI
|
4 | $ 1.42 | 0.71 % | $ 402 M | Canada |
 |
Veru
VERU
|
2.15 | $ 2.26 | 0.44 % | $ 305 M | USA |
 |
Evolus
EOLS
|
0.907 | $ 5.33 | -1.11 % | $ 344 M | USA |
 |
Sundial Growers
SNDL
|
5.69 | $ 1.41 | 3.68 % | $ 3.37 M | Canada |
 |
Emergent BioSolutions
EBS
|
1.55 | $ 8.47 | 2.67 % | $ 434 M | USA |
 |
Organogenesis Holdings
ORGO
|
4.42 | $ 2.57 | 9.36 % | $ 338 M | USA |
 |
Neoleukin Therapeutics
NLTX
|
12.2 | - | - | $ 193 M | Canada |
 |
cbdMD
YCBD
|
1.23 | $ 0.87 | 0.14 % | $ 3.75 M | USA |
 |
ProPhase Labs
PRPH
|
3.65 | - | - | $ 5.07 M | USA |
 |
Radius Health
RDUS
|
0.418 | - | - | $ 1.42 B | USA |
 |
Assertio Holdings
ASRT
|
1.54 | $ 18.47 | 0.22 % | $ 118 M | USA |
 |
PetIQ
PETQ
|
2.4 | - | 1.64 % | $ 400 M | USA |
 |
Relmada Therapeutics
RLMD
|
12.5 | $ 7.64 | 1.6 % | $ 302 M | USA |
 |
Recro Pharma
REPH
|
1.62 | - | -4.76 % | $ 65.3 M | USA |
 |
OptiNose
OPTN
|
0.554 | - | - | $ 1.08 B | USA |
 |
SCYNEXIS
SCYX
|
6.12 | $ 0.99 | 6.48 % | $ 49.4 M | USA |
 |
PLx Pharma
PLXP
|
3.07 | - | -27.8 % | $ 2.56 M | USA |
 |
Viatris
VTRS
|
1.73 | $ 15.04 | 0.67 % | $ 18.1 B | USA |
 |
Zomedica Corp.
ZOM
|
10.9 | - | -0.21 % | $ 98 M | USA |
 |
Zynerba Pharmaceuticals
ZYNE
|
5.98 | - | - | $ 55.5 M | USA |
 |
Rockwell Medical
RMTI
|
2.83 | $ 0.89 | 1.29 % | $ 32 M | USA |
 |
Tricida
TCDA
|
1 | - | - | $ 3.25 M | USA |
 |
China Pharma Holdings
CPHI
|
3.75 | $ 0.53 | -2.39 % | $ 2.27 M |  China |
 |
TherapeuticsMD
TXMD
|
3.49 | $ 2.07 | 1.47 % | $ 23.9 M | USA |